Smile Spa Camarillo is equipped to provide a full spectrum of services ranging from general, cosmetic, surgical, and emergency dental services. This all-in-one approach reduces the need for external ...

Traditional oxytocin delivery methods—whether injectable or intranasal—require continuous administration due to the hormone's extremely short half-life of just minutes in the bloodstream. Maximus ...

Nanox (NASDAQ: NNOX) is focused on driving the world’s transition to preventive health care by bringing a full solution of affordable medical imaging technologies based on advanced AI and proprietary ...

BillionToOne, Inc., a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the closing of its upsized initial public offering ...

NANTES, France, November 7, 2025 – 6:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a clinical-stage biotechnology company developing immunotherapies for cancer and autoimmune ...

Company also expects to publish third quarter 2025 financial results on the same day pre-market ...

Protext Mobility, Inc. (OTC: TXTM) Announces Launch Phase of Its Next-Generation Investor Relations Suite and Corporate Website Modernization — Ushering in a New Era of Transparency, Innovation, and ...

All Smiles Dental Studio, a leading dental care provider serving North County San Diego, is pleased to announce the expansion of its services by offering comprehensive dental implant solutions, ...

Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 60-cents per share on the Company’s capital stock, payable on December 5, 2025, to ...

Neurocept, the newly spotlighted cognitive enhancement innovation for 2025, has officially entered the U.S. wellness market, setting a new standard in clinically inspired brain health solutions.

DALLAS, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc. ® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today released its financial and business results for the ...

XPHOZAH is the first and only phosphate absorption inhibitor (PAI) approved by the U.S. Food and Drug Administration to reduce serum phosphorus in adults with chronic kidney disease on dialysis as add ...